Chris @ MedRight
@medright_comms
Freelance medical writer and medical communications consultant with a passion for science and health.
#MedComms #SciComm #MedRight #Health #Science
ID: 1242208659750260736
http://www.medrightmedicalwriting.com 23-03-2020 21:58:22
879 Tweet
483 Followers
1,1K Following
Danish study shows #colorectal #cancer recurrence rates have dropped from 2004 to 2019. Lower-stage cancers had longer time to recurrence and better outcomes, highlighting the need for personalized surveillance. Aarhus Uni.hospital Claus Lindbjerg Andersen Jesper Nors buff.ly/490khfI
๐ฅoff the press: ESMO Open Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer ๐Great consensus with our Asian friends & colleagues ๐my personal link to share: authors.elsevier.com/sd/article/S20โฆ ESMO - Eur. Oncology
๐๐ฉ๐๐ง๐๐๐๐๐๐-1: ๐๐๐ง๐๐ซ๐๐ญ๐ข๐ฏ๐ ๐๐ ๐๐๐๐ญ๐ฌ ๐๐๐๐๐๐ Researchers at Profluent used large language models to expand the sequence diversity of CRISPR-Cas proteins and generate novel, functional genome editors with improved properties compared to natural
mFOLFOX plus/minus Nivo & Ipi vs FLOT + nivolumab in metastatic G/GEJ adenocarcinoma #ESMO24 ๐IKF-AIO-Moonlight trial ๐ORR 46 vs 32 vs 47 vs 56% ๐PFS: 5,8 vs 4 vs 6,6 vs 7 mo ๐mOS: 10 vs 7,6 vs 12,5 vs 14,6 mo ๐งOnly FLOT + Nivo seems feasible & effective ESMO - Eur. Oncology
Neoadjuvant immunotherapy in locally advanced MMR-deficient colon cancer: #ESMO24 ๐3-year disease-free survival from NICHE-2 ๐๐ฏ% DFS ๐all MRD pts cleared ctDNA ๐งImpressive results, ctDNA may be helpful to select for organ preservation ESMO - Eur. Oncology #ESMOAmbassadors